跳至主要内容
临床试验/JPRN-jRCTs031210365
JPRN-jRCTs031210365招募中2 期

JCOG2006: A randomized phase II study comparing preoperative adjuvant chemotherapy with mFOLFOX6 versus FOLFOXIRI for resectable locally advanced colon cancer - NAC-CC ranPII

TAKII Yasumasa0 个研究点目标入组 86 人开始时间: 2021年10月4日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 75age old(—)
性别
All

入选标准

  • (1) Pathologically proven colorectal adenocarcinoma with endoscopic biopsy specimen.
  • (2) Tumor is mainly located between cecum and rectal sigmoid colon.
  • (3) Diagnosed on contrast-enhanced abdominal/pelvic CT(<=1.25mm) either (a) or (b)
  • (a) cT4b and cN+
  • (b) cT3-T4a and cN2-3
  • (4) No distant metastasis on chest CT and contrast-enhanced abdominal/pelvic CT (cM0).
  • (5) Age, 18 - 75 years old.
  • (6) ECOG Performance status, 0 or 1.
  • (7) No prior chemotherapy.
  • (8) No multiple colorectal cancer diagnosed on colonscopy and imaging test.
  • (9) UGT1A1 genotypes that do not include *6/*6, *28/*28, or *6/*28.
  • (10) Sufficient organ function.
  • (a) Neutrophil count >= 1,500 /mm3
  • (b) Hemoglobin >= 8.0 mg/dL
  • (c) Platelet count >= 100,000 /mm3
  • (d) AST =< 100 U/L
  • (e) ALT =< 100 U/L
  • (f) Total Bilirubin =< 2.0 mg/dL
  • (g) Cr =< 1.5 mg/dL
  • (11) Without ileus or bowel perforation.
  • (12) Written informed consent is obtained.

排除标准

  • (1) Synchronous or metachronous (within 5 years) malignancies
  • (2) Infections which needs systemic treatment.
  • (3) Body temperature is higher than 38 degrees centigrade at registration.
  • (4) Female during pregnancy, within 28 days of postparturition, or during lactation. Male who wants partner's pregnancy.
  • (5) Severe psychological disease.
  • (6) Continuous systemic corticosteroid or immunosuppressant treatment.
  • (7) Uncontrollable diabetes mellitus.
  • (8) Uncontrollable hypertension.
  • (9) Unstable angina pectoris, or history of myocardial infarction within 6 months.
  • (10) Uncontrollable valvular heart disease, dilated cardiomyopathy, or hypertrophic cardiomyopathy.
  • (11) Regularly using phenytoin.
  • (12) Interstitial pneumonia, pulmonary fibrosis, severe emphysema diagnosed on chest CT.

研究者

发起方
TAKII Yasumasa

相似试验

招募中
2 期
JCOG2204: A randomized phase II study to compare the pathological responses of neoadjuvant chemotherapy for type 4 or large type 3 gastric cancer: 5-FU, Oxaliplatin and Docetaxel (FLOT) versus Docetaxel, Oxaliplatin and S-1 (DOS)Resectable large type 3 or type 4 gastric cancer
JPRN-jRCTs031230231OHASHI Manabu76
已完成
2 期
JCOG1207: A randomized controlled phase II/III study comparing EBD combined with steroid versus RIC combined with steroid for refractory anastomotic stricture after esophagectomyRefractory anastomotic stricture after surgical resection for esophageal cancer
JPRN-jRCTs031180177MUTO Manabu130
招募中
3 期
JCOG2206: A randomized controlled phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced esophageal squamous cell carcinoma with no pathological complete response after neoadjuvant chemotherapy followed by curative esophagectomyEsophageal squamous cell carcinoma with no pathological complete response after neoadjuvant therapy
JPRN-jRCTs031230219KITAGAWA Yuko450
进行中(未招募)
不适用
Randomized Phase II AGO-Study comparing combined liposomal doxorubicin (Myocet) and gemcitabine (Gemzar) with liposomal doxorubicin (Myocet) monotherapy in platinum-refractory and platinum-resistant epithelial cancer of the ovary, fallopian tube, and the peritoneum - AGO 10
EUCTR2008-008746-20-ATStudienzentrale AGO Austria154
招募中
3 期
JCOG1701: Randomized phase III study comparing cessation or continuation of PD-1 Pathway Blockade for patients with advanced non-small-cell lung cancer
JPRN-jRCT1031190032OHE Yuichiro172